{"id":11236,"date":"2022-11-03T23:17:37","date_gmt":"2022-11-03T22:17:37","guid":{"rendered":"https:\/\/netzwerk-homoeopathie.info\/?p=11236"},"modified":"2023-02-17T02:00:10","modified_gmt":"2023-02-17T01:00:10","slug":"frass-et-al-2020-pressemitteilung-inh-mit-update-2022-11-03","status":"publish","type":"post","link":"https:\/\/netzwerk-homoeopathie.info\/en\/frass-et-al-2020-pressemitteilung-inh-mit-update-2022-11-03\/","title":{"rendered":"Homeopathic Treatment as an Add-On Therapy May Improve Quality of Life and Prolong Survival in Patients with Non-Small Cell Lung Cancer (Frass et al 2020) – INH Press releases 31.10. \/ 03.11.2022"},"content":{"rendered":"Lesedauer \/ Reading Time:<\/span> 6<\/span> min<\/span><\/span>

\"\"<\/p>\n

Press release \u2013 Update<\/h1>\n

Independent Scientific Agency:
\nCelebrated homeopathy study based on data manipulation and falsification<\/h2>\n

Update, 03.11.2022<\/strong><\/p>\n

The publishing journal, The Oncologist, has today published an expression of concern on the study in question, Frass et al. (2020). With an Expression of concern, the publishers (here: Oxford University Press) inform that there are doubts about the validity of the publication. The Oncologist is now conducting its own review of the Austrian Agency for Scientific Integrity’s investigative findings. Until this is completed and a final decision is made on whether to withdraw the study, its results may have to be assessed as “not reliable”.<\/p>\n

https:\/\/academic.oup.com\/oncolo\/advance-article\/doi\/10.1093\/oncolo\/oyac221\/6782256<\/a><\/p>\n

\n

The original press release:<\/p>\n

“Some results can only be explained by manipulation or falsification”. With this assessment, the Austrian Agency for Scientific Integrity (\u00d6AWI) has now confirmed the findings of a working group from Germany and Austria that had examined a study on homeopathy in lung cancer patients. This conclusively disproves this study, which had been hailed as convincing evidence of efficacy beyond placebo since its publication in October 2020 – and homeopathy research has hit a new low.<\/strong><\/p>\n

\n

What had happened?<\/strong><\/p>\n

In October 2020, a clinical trial of homeopathic adjunctive treatment for patients with advanced lung cancer appeared in the prestigious medical journal The Oncologist. At first glance the study seemed to be of high quality and came to sensational results: Patients treated with homeopathy lived about 70% longer than placebo-treated patients. With homeopathy patients also gained significantly in quality of life, while the others were getting worse.<\/p>\n

An in-depth analysis by a German-Austrian working group revealed numerous indications that the data could have been manipulated and falsified:<\/p>\n